Guanylyl cyclase-dependent chemotaxis of endothelial cells in response to nitric oxide gradients.
Nitric oxide (NO) is an important regulator of angiogenesis and neovascularization. The nature of endothelial cell motility responses to NO was examined using a Boyden chamber method. NO generated via decomposition of either DEA/NO or DETA/NO produced increases in human umbilical vein endothelial cell (HUVEC) chemotaxis, which were completely abrogated by ODQ, a soluble guanylyl cyclase inhibitor. Measurements of NO either directly by chemiluminescence or its chemistry with diaminofluorescein revealed that chemotaxis was driven by subtle NO gradients between the lower and the upper wells in this system. In addition to diffusion and volatilization from the upper chambers, the data showed that HUVEC consumption of NO contributed to these sustained gradients. Comparison of DEA/NO- and DETA/NO-mediated responses suggested that the persistence of spatial NO gradients is as significant as the absolute magnitude of NO exposure per unit time. The findings suggest that subnanomolar NO gradients are sufficient to mobilize endothelial cell migration into hypoxic tissue during neovascularization events, such as in wound healing and cancer.
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. isenberj@mail.nih.gov
Jeff S
JS
Isenberg
Lisa A
LA
Ridnour
Douglas D
DD
Thomas
David A
DA
Wink
David D
DD
Roberts
Michael Graham
MG
Espey
D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D002633:Chemotaxis / Q000187:drug effects*; D004058:Diffusion; D042783:Endothelial Cells / Q000187:drug effects* / Q000502:physiology; D004730:Endothelium, Vascular / Q000166:cytology; D006162:Guanylate Cyclase / Q000502:physiology*; D006801:Humans; D006834:Hydrazines / Q000378:metabolism; D018919:Neovascularization, Physiologic; D009569:Nitric Oxide / Q000494:pharmacology; D009589:Nitrogen Oxides / Q000378:metabolism; D010069:Oxadiazoles / Q000494:pharmacology; D011810:Quinoxalines / Q000494:pharmacology; D014226:Triazenes / Q000378:metabolism; D014835:Volatilization
C105351:1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene; C095284:1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one; D006834:Hydrazines; D009589:Nitrogen Oxides; D010069:Oxadiazoles; D011810:Quinoxalines; D014226:Triazenes; D009569:Nitric Oxide; C084012:1,1-diethyl-2-hydroxy-2-nitrosohydrazine; D006162:Guanylate Cyclase